Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Common Equity (2020 - 2025)

Historic Common Equity for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $447.7 million.

  • Cellebrite DI's Common Equity rose 5007.07% to $447.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.7 million, marking a year-over-year increase of 5007.07%. This contributed to the annual value of $336.0 million for FY2024, which is 88217.0% up from last year.
  • Per Cellebrite DI's latest filing, its Common Equity stood at $447.7 million for Q3 2025, which was up 5007.07% from $408.4 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Common Equity registered a high of $447.7 million during Q3 2025, and its lowest value of -$73.3 million during Q4 2021.
  • Its 5-year average for Common Equity is $163.1 million, with a median of $56.6 million in 2022.
  • In the last 5 years, Cellebrite DI's Common Equity plummeted by 21495.67% in 2021 and then surged by 146109.49% in 2025.
  • Over the past 5 years, Cellebrite DI's Common Equity (Quarter) stood at -$73.3 million in 2021, then soared by 200.71% to $73.9 million in 2022, then tumbled by 53.68% to $34.2 million in 2023, then skyrocketed by 882.17% to $336.0 million in 2024, then skyrocketed by 33.23% to $447.7 million in 2025.
  • Its last three reported values are $447.7 million in Q3 2025, $408.4 million for Q2 2025, and $363.5 million during Q1 2025.